CY1122805T1 - Ενωσεις και μεθοδοι για την αγωγη βακτηριακων λοιμωξεων - Google Patents
Ενωσεις και μεθοδοι για την αγωγη βακτηριακων λοιμωξεωνInfo
- Publication number
- CY1122805T1 CY1122805T1 CY20201100217T CY201100217T CY1122805T1 CY 1122805 T1 CY1122805 T1 CY 1122805T1 CY 20201100217 T CY20201100217 T CY 20201100217T CY 201100217 T CY201100217 T CY 201100217T CY 1122805 T1 CY1122805 T1 CY 1122805T1
- Authority
- CY
- Cyprus
- Prior art keywords
- compounds
- bacterial infections
- methods
- treating bacterial
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Αποκαλύπτονται ενώσεις του τύπου (Ι), φαρμακευτικά αποδεκτά άλατα αυτών και χρήσεις των ενώσεων του τύπου (Ι) για την αγωγή βακτηριακών λοιμώξεων.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361755537P | 2013-01-23 | 2013-01-23 | |
| US201361859910P | 2013-07-30 | 2013-07-30 | |
| PCT/GB2014/050164 WO2014114929A1 (en) | 2013-01-23 | 2014-01-22 | Compounds and methods for treating bacterial infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1122805T1 true CY1122805T1 (el) | 2021-05-05 |
Family
ID=50033593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20201100217T CY1122805T1 (el) | 2013-01-23 | 2020-03-12 | Ενωσεις και μεθοδοι για την αγωγη βακτηριακων λοιμωξεων |
Country Status (31)
| Country | Link |
|---|---|
| US (4) | US8889671B2 (el) |
| EP (1) | EP2948461B1 (el) |
| JP (1) | JP6285960B2 (el) |
| KR (1) | KR102149567B1 (el) |
| CN (1) | CN105229012B (el) |
| AR (1) | AR094565A1 (el) |
| AU (1) | AU2014208965B2 (el) |
| BR (1) | BR112015017519B1 (el) |
| CA (1) | CA2897887C (el) |
| CY (1) | CY1122805T1 (el) |
| DK (1) | DK2948461T3 (el) |
| EA (1) | EA026901B1 (el) |
| ES (1) | ES2780824T3 (el) |
| HK (1) | HK1218293A1 (el) |
| HR (1) | HRP20200401T1 (el) |
| HU (1) | HUE048990T2 (el) |
| IL (1) | IL239860A0 (el) |
| LT (1) | LT2948461T (el) |
| ME (1) | ME03676B (el) |
| MX (1) | MX360650B (el) |
| MY (1) | MY192765A (el) |
| NZ (1) | NZ710091A (el) |
| PH (1) | PH12015501588A1 (el) |
| PL (1) | PL2948461T3 (el) |
| PT (1) | PT2948461T (el) |
| RS (1) | RS60078B1 (el) |
| SG (1) | SG11201505462YA (el) |
| SI (1) | SI2948461T1 (el) |
| TW (1) | TWI603973B (el) |
| UY (1) | UY35274A (el) |
| WO (1) | WO2014114929A1 (el) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9040528B2 (en) * | 2008-10-14 | 2015-05-26 | Astrazeneca Ab | Chemical compounds 542 |
| US8889671B2 (en) * | 2013-01-23 | 2014-11-18 | Astrazeneca Ab | Compounds and methods for treating bacterial infections |
| EP3148546A1 (en) * | 2014-05-29 | 2017-04-05 | Entasis Therapeutics Limited | Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections |
| CN108136211A (zh) * | 2015-10-29 | 2018-06-08 | 马里兰大学派克分院 | 用于抑制人宫颈内膜中的细菌感染的组合物和方法 |
| CN106632298B (zh) * | 2015-11-03 | 2021-06-01 | 上海科胜药物研发有限公司 | 一种泰地唑胺的制备方法及其中间体 |
| MY201325A (en) | 2017-06-01 | 2024-02-16 | Bristol Myers Squibb Co | Substituted nitrogen containing compounds |
| WO2018233670A1 (zh) * | 2017-06-22 | 2018-12-27 | 中国科学院上海药物研究所 | 苯并异噁唑螺嘧啶三酮类化合物及制备方法和用途 |
| CN109111466B (zh) * | 2017-06-22 | 2022-08-02 | 中国科学院上海药物研究所 | 苯并异噁唑螺嘧啶三酮类化合物及制备方法和用途 |
| CN109111465B (zh) * | 2017-06-22 | 2021-01-12 | 中国科学院上海药物研究所 | 噻唑烷酮螺嘧啶三酮类化合物及制备方法和用途 |
| CN108060207B (zh) * | 2017-12-29 | 2021-10-15 | 河南科技大学 | 一种基于微量天然化合物的最小杀菌浓度测定方法 |
| US11905286B2 (en) | 2018-08-09 | 2024-02-20 | Antabio Sas | Diazabicyclooctanones as inhibitors of serine beta-lactamases |
| CN111559985A (zh) * | 2020-05-13 | 2020-08-21 | 河南科技大学第一附属医院 | 具有杀菌作用的噁唑酮类化合物及其制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0759570B2 (ja) | 1986-05-06 | 1995-06-28 | 三井東圧化学株式会社 | ２−オキサゾリジノン類の製造方法 |
| US7208490B2 (en) | 2002-10-07 | 2007-04-24 | Pharmacia & Upjohn Company Llc | Tricyclic tetrahydroquinoline antibacterial agents |
| DE602004019548D1 (de) | 2003-08-15 | 2009-04-02 | Astrazeneca Ab | Kondensierte heterocyclen als inhibitoren von glutamatracemase (muri) |
| WO2005066119A2 (en) | 2003-12-31 | 2005-07-21 | Schering-Plough Ltd. | Antibacterial 1-(4-mono-and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoropropanols and preparation thereof |
| CA2606847A1 (en) | 2005-05-09 | 2006-11-16 | Warner-Lambert Company Llc | Antibacterial agents |
| DOP2006000268A (es) | 2005-12-22 | 2007-07-31 | Pfizer Prod Inc | Agentes antibacterianos |
| CL2007003332A1 (es) * | 2006-11-24 | 2008-06-20 | Actelion Pharmaceuticals Ltd | Compuestos derivados de heterociclos condensados; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o tratamiento de infecciones bacterianas. |
| WO2009004382A2 (en) | 2007-07-02 | 2009-01-08 | Astrazeneca Ab | 3-spiropyrimidinetrione-quinoline derivatives and their use as antibacterial agents |
| US9040528B2 (en) | 2008-10-14 | 2015-05-26 | Astrazeneca Ab | Chemical compounds 542 |
| BRPI0920180B1 (pt) | 2008-10-14 | 2021-10-26 | Entasis Therapeutics Limited | Compostos herecíclicos substituídos, uso dos mesmos e composiçâo farmacêutica compreendendo os ditos compostos |
| US8952149B2 (en) | 2012-09-26 | 2015-02-10 | Zoetis Llc | Tricyclic tetrahydroquinoline antibacterial agents |
| US8889671B2 (en) * | 2013-01-23 | 2014-11-18 | Astrazeneca Ab | Compounds and methods for treating bacterial infections |
-
2014
- 2014-01-21 US US14/159,773 patent/US8889671B2/en active Active
- 2014-01-22 EA EA201591362A patent/EA026901B1/ru unknown
- 2014-01-22 PL PL14702642T patent/PL2948461T3/pl unknown
- 2014-01-22 WO PCT/GB2014/050164 patent/WO2014114929A1/en active Application Filing
- 2014-01-22 HU HUE14702642A patent/HUE048990T2/hu unknown
- 2014-01-22 ES ES14702642T patent/ES2780824T3/es active Active
- 2014-01-22 CN CN201480017715.6A patent/CN105229012B/zh active Active
- 2014-01-22 CA CA2897887A patent/CA2897887C/en active Active
- 2014-01-22 MY MYPI2015001807A patent/MY192765A/en unknown
- 2014-01-22 KR KR1020157022580A patent/KR102149567B1/ko active IP Right Grant
- 2014-01-22 EP EP14702642.1A patent/EP2948461B1/en active Active
- 2014-01-22 SI SI201431524T patent/SI2948461T1/sl unknown
- 2014-01-22 JP JP2015554245A patent/JP6285960B2/ja active Active
- 2014-01-22 DK DK14702642.1T patent/DK2948461T3/da active
- 2014-01-22 NZ NZ710091A patent/NZ710091A/en unknown
- 2014-01-22 ME MEP-2020-55A patent/ME03676B/me unknown
- 2014-01-22 AU AU2014208965A patent/AU2014208965B2/en active Active
- 2014-01-22 PT PT147026421T patent/PT2948461T/pt unknown
- 2014-01-22 RS RS20200292A patent/RS60078B1/sr unknown
- 2014-01-22 LT LTEP14702642.1T patent/LT2948461T/lt unknown
- 2014-01-22 SG SG11201505462YA patent/SG11201505462YA/en unknown
- 2014-01-22 BR BR112015017519-8A patent/BR112015017519B1/pt active IP Right Grant
- 2014-01-22 MX MX2015009479A patent/MX360650B/es active IP Right Grant
- 2014-01-23 UY UY0001035274A patent/UY35274A/es not_active Application Discontinuation
- 2014-01-23 TW TW103102537A patent/TWI603973B/zh active
- 2014-01-23 AR ARP140100208A patent/AR094565A1/es active IP Right Grant
- 2014-10-16 US US14/515,684 patent/US9187495B2/en active Active
-
2015
- 2015-07-09 IL IL239860A patent/IL239860A0/en active IP Right Grant
- 2015-07-20 PH PH12015501588A patent/PH12015501588A1/en unknown
- 2015-10-13 US US14/881,595 patent/US9540394B2/en active Active
-
2016
- 2016-06-01 HK HK16106237.2A patent/HK1218293A1/zh unknown
- 2016-11-16 US US15/353,325 patent/US9839641B2/en active Active
-
2020
- 2020-03-11 HR HRP20200401TT patent/HRP20200401T1/hr unknown
- 2020-03-12 CY CY20201100217T patent/CY1122805T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1122805T1 (el) | Ενωσεις και μεθοδοι για την αγωγη βακτηριακων λοιμωξεων | |
| PH12019501321B1 (en) | Use of pyrazolopyrimidine derivatives for the treatment of pi3k-delta related disorders | |
| CY1121701T1 (el) | Οργανικες ενωσεις μονοβακταμης για την αντιμετωπιση βακτηριακων λοιμωξεων | |
| MX2016013689A (es) | Compuestos 4-amino-imidazoquinolina. | |
| MX2016006432A (es) | Tetrahidro-benzodiazepinonas. | |
| MX2015017964A (es) | Inhibidores de bromodominio. | |
| MX2017000312A (es) | Derivados de isoindolina para usarse en el tratamiento de una infeccion viral. | |
| EA201790327A1 (ru) | Соединения замещенного пиперидина | |
| EA201591024A1 (ru) | Димерные соединения | |
| BR112017026061A2 (pt) | composto, uso de um composto, e, método de tratamento de uma infecção viral | |
| EA201591399A1 (ru) | РАППγ АГОНИСТЫ ДЛЯ ЛЕЧЕНИЯ РАССЕЯННОГО СКЛЕРОЗА | |
| EA201691566A1 (ru) | Применение производных пиридазина для предупреждения или лечения атаксического синдрома | |
| EA201690227A1 (ru) | Азаиндольные соединения, их получение и способы их применения | |
| EA201790687A1 (ru) | Хинолинкарбоксамиды для применения в лечении множественной миеломы | |
| EA201690075A1 (ru) | Способ лечения внутриклеточной инфекции | |
| MX363631B (es) | Composiciones y metodos para tratar infecciones bacterianas. | |
| EA201791099A1 (ru) | Хинолин карбоксамиды для применения в лечении лейкоза | |
| EA201590347A1 (ru) | Азагетероциклы в качестве ингибиторов bir2 и/или bir3 | |
| EA201590656A1 (ru) | Азаиндолины | |
| CL2015003431A1 (es) | Derivados de piridona para el tratamiento de infecciones virales y enfermedades adicionales | |
| IN2013MU03216A (el) | ||
| MX360040B (es) | Nuevo agente antibacteriano derivado de florfenicol unido a sulfoximina y el uso del mismo en el tratamiento de infecciones bacterianas en ganado vacuno. | |
| SG10201903630UA (en) | Iminosugars useful for the treatment of viral diseases | |
| EA202090336A1 (ru) | Соединения, их соли и способы лечения заболеваний | |
| JO3477B1 (ar) | مركبات أحادي باكتام عضوية لعلاج العدوى البكتيرية |